Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 0.0 | 0.7 | 11.3 | 8.8 | 7.8 | 3.2 |
| Revenue growth | -100.0% | -94.3% | 28.3% | 13.6% | 141.9% | |
| Cost of goods sold | 0.0 | 0.0 | 22.6 | 17.6 | 15.5 | 6.4 |
| Gross profit | 0.0 | 0.7 | -11.3 | -8.8 | -7.8 | -3.2 |
| Gross margin | | 100.0% | -100.0% | -100.0% | -100.0% | -100.0% |
| Selling, general and administrative | 9.4 | 4.8 | 3.1 | 3.1 | 1.9 | 1.4 |
| Research and development | 12.4 | 17.1 | | | | |
| EBIT | -21.8 | -21.2 | -14.5 | -11.9 | -9.6 | -4.6 |
| EBIT margin | | -3259.4% | -127.8% | -134.9% | -124.3% | -142.5% |
| Pre-tax income | -23.2 | -24.9 | -15.7 | -17.5 | -9.7 | -5.2 |
| Income taxes | 0.0 | -0.5 | -0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.2% | 2.0% | 1.0% | 0.0% | 0.0% | 0.0% |
| Net income | -23.2 | -26.9 | -15.6 | -17.5 | -10.8 | -5.6 |
| Net margin | | -4136.9% | -137.9% | -198.6% | -139.2% | -173.2% |
| |
| Diluted EPS | ($1.58) | ($4.39) | ($40.83) | ($45.88) | ($29.38) | ($16.25) |
| Shares outstanding (diluted) | 14.6 | 6.1 | 0.4 | 0.4 | 0.4 | 0.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|